Cargando…
Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma
SIMPLE SUMMARY: A critical step in the success of immunotherapy is the presentation of tumor-derived peptides by the major histocompatibility complex I (MHC-I) of tumor cells. These neoantigens are potentially immunogenic and trigger immune responses orchestrated by cytotoxic cells. In malignant mes...
Autores principales: | Brossel, Hélène, Fontaine, Alexis, Hoyos, Clotilde, Jamakhani, Majeed, Willems, Mégane, Hamaidia, Malik, Willems, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269013/ https://www.ncbi.nlm.nih.gov/pubmed/34199066 http://dx.doi.org/10.3390/cancers13133211 |
Ejemplares similares
-
Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
por: Willems, Mégane, et al.
Publicado: (2023) -
HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells
por: Hoyos, Clotilde, et al.
Publicado: (2022) -
How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?
por: Gazon, Hélène, et al.
Publicado: (2018) -
TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
por: Staumont, Bernard, et al.
Publicado: (2020) -
BLV: lessons on vaccine development
por: Abdala, Alejandro, et al.
Publicado: (2019)